High Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis

BACKGROUND: Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). METHODS: One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of high-dose UDC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lindor, Keith D., Kowdley, Kris V., Luketic, Velimir A. C., Harrison, M. Edwyn, McCashland, Timothy, Befeler, Alex S., Harnois, Denise, Jorgensen, Roberta, Petz, Jan, Keach, Jill, Mooney, Jody, Sargeant, Carol, Braaten, Julie, Bernard, Tamara, King, Debra, Miceli, Ellen, Schmoll, Jeff, Hoskin, Tanya, Thapa, Prabin, Enders, Felicity
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758780/
https://ncbi.nlm.nih.gov/pubmed/19585548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.23082
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars